维普期刊资源整合服务平台（V6.5）

775篇 您的检索式：作者名="NAUCK"

选中清除导出查看参考文献查看引证文献引用追踪共39页首页上一页第1页下一页末页 /39 跳转

	题名	作者	年代	出处	被引量
1	Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘	Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R	2012	EN2012，，3：	6
2	The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes显示文摘	Daniel J Drucker Michael A Nauck	2006	2006 (9548)2006，，9548：	3
3	Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance显示文摘	Ritzel R Schulte M Nauck M A	2001	Diabetes2001，50，：	2
4	A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study显示文摘	M. A. Nauck S. Duran D. Kim D. Johns J. Northrup A. Festa R. Brodows M. Trautmann	2007	Diabetologia2007，，2：	2
5	Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study显示文摘	Nauck Michael Frid Anders Hermansen Kjeld Shah Nalini S Tankova Tsvetalina Mitha Ismail H Zdravkovic Milan Düring Maria Matthews David R	2009	Diabetes Care2009，，：	2
6	Efficacy and safety comparison of liraglutide,glimepiride,and placebo,all in combination with metformin,in type 2 diabetes:the LEAD (liraglutide effect and action in diabetes)-2 study显示文摘	Nauck M Frid A Hermansen K		Diabetes Care0，，：	2
7	Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘	S. E. Inzucchi R. M. Bergenstal J. B. Buse M. Diamant E. Ferrannini M. Nauck A. L. Peters A. Tsapas R. Wender D. R. Matthews	2012	Diabetologia2012，，6：	2
8	Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemie control and lowers body weight in subjects with type 2 diabetes显示文摘	Nauck MA Hompesch M Filipczak R	2006	Exp Clin Endocrinol Diabetes2006，114，8：	1
9	GLP-1R agonists (incretin mimetics ) andDPP-4 inhibitors ( incretin enhancers ) for the treatment of tupe 2diabetds显示文摘	Drucder D J Nauck M A	2006	Lancet2006，368，9：	1
10	A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study显示文摘	Nauck MA Duran S Kim D	2007	Diabetologia2007，50，2：	1
11	Unraveling the science of incretin biology显示文摘	Nauck MA	2009	Am JMed2009，122，6：	1
12	Towards the automation of intelligent data analysis显示文摘	Spott M Nauck D	2006	Applied Soft Computing2006，6，8：	1
13	Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes显示文摘	Maggs D MacDonald I Nauck M A	2008	Diabetes Obes Metab2008，10，1：	1
14	A comparison of twicedaily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a noninferiority study 显示文摘	Nauck MA Duran S Kim D	2007	Diabetologia2007，50，2：	1
15	Glucagon-like peptide 1 (GLP-1) and its derivatives in the treatment of diabetes显示文摘	Nauck MA Meier JJ	2005	Regul Pept2005，124，：	1
16	Additive insulinotropie effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon- like peptide-l(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations显示文摘	Nauck MA Barrels E Orskov C	1993	J Clin Endocrinol Metab1993，76，4：	1
17	Glucagon-like peptide-1 in type 2 diabetes:theβcell and beyond显示文摘	Nauck M	2008	Diabetes Obes Metab2008，10，3：	1
18	The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 irthibitors in type 2 diabetes 显示文摘	Drucker D J Nauck MA	2006	Lancet2006，368，9548：	1
19	Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome 显示文摘	Krueger M Heinzmann A Nauck M	2007	Intensive Care Med2007，33，2：	1
20	Proliferation of human non- small-cell lung cancer cell lines : role of interleukin-6 显示文摘	BIHL M TAMM M NAUCK M	1998	Am J Respir Cell Mol Biol1998，19，4：	1

返回顶部每页显示：

共39页首页上一页第1页下一页末页 /39 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示